Literature DB >> 34981502

Boosting GLP-1 by Natural Products.

Habib Yaribeygi1, Tannaz Jamialahmadi2,3, Seyed Adel Moallem4,5, Amirhossein Sahebkar6,7,8.   

Abstract

The prevalence of diabetes mellitus is growing rapidly. Diabetes is the underlying cause of many metabolic and tissue dysfunctions, and, therefore, many therapeutic agents have been developed to regulate the glycemic profile. Glucagon-like peptide-1 (GLP-1) receptor agonists are a newly developed class of antidiabetic drugs that have potent hypoglycemic effects via several molecular pathways. In addition to synthetic GLP-1 receptor agonists, some evidence suggests that natural products may have modulatory effects on GLP-1 expression and secretion. In the current study, we conclude that certain herbal-based constituents, such as berberine, tea, curcumin, cinnamon, wheat, soybean, resveratrol, and gardenia, can exert an influence on GLP-1 release.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Berberine; Cinnamon; Curcumin; Diabetes mellitus; GLP-1 agonist; Resveratrol

Mesh:

Substances:

Year:  2021        PMID: 34981502     DOI: 10.1007/978-3-030-73234-9_36

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  60 in total

1.  Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.

Authors:  Elizabeth J Mayer-Davis; Jean M Lawrence; Dana Dabelea; Jasmin Divers; Scott Isom; Lawrence Dolan; Giuseppina Imperatore; Barbara Linder; Santica Marcovina; David J Pettitt; Catherine Pihoker; Sharon Saydah; Lynne Wagenknecht
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

Review 2.  MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.

Authors:  Habib Yaribeygi; Niki Katsiki; Behzad Behnam; Helia Iranpanah; Amirhossein Sahebkar
Journal:  Metabolism       Date:  2018-07-03       Impact factor: 8.694

3.  Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women.

Authors:  Caroline Montelius; Daniel Erlandsson; Egzona Vitija; Eva-Lena Stenblom; Emil Egecioglu; Charlotte Erlanson-Albertsson
Journal:  Appetite       Date:  2014-06-30       Impact factor: 3.868

Review 4.  Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.

Authors:  C F Deacon; E Mannucci; B Ahrén
Journal:  Diabetes Obes Metab       Date:  2012-04-24       Impact factor: 6.577

Review 5.  Sodium-glucose cotransporter inhibitors and oxidative stress: An update.

Authors:  Habib Yaribeygi; Stephen L Atkin; Alexandra E Butler; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2018-11-15       Impact factor: 6.384

Review 6.  A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress.

Authors:  Habib Yaribeygi; Stephen L Atkin; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2018-08-26       Impact factor: 6.384

Review 7.  Narrative review of the effects of antidiabetic drugs on albuminuria.

Authors:  Habib Yaribeygi; Stephen L Atkin; Niki Katsiki; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2018-10-26       Impact factor: 6.384

8.  Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control.

Authors:  Thi-Mai Anh Dao; Aurélie Waget; Pascale Klopp; Matteo Serino; Christelle Vachoux; Laurent Pechere; Daniel J Drucker; Serge Champion; Sylvain Barthélemy; Yves Barra; Rémy Burcelin; Eric Sérée
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

Review 9.  A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond.

Authors:  Lalita Prasad-Reddy; Diana Isaacs
Journal:  Drugs Context       Date:  2015-07-09

10.  GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.

Authors:  Gulzar Ahmad Bhat; Haseeb A Khan; Abdullah S Alhomida; Poonam Sharma; Rambir Singh; Bilal Ahmad Paray
Journal:  BMC Complement Altern Med       Date:  2018-05-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.